Hexavalent combined vaccination;La vaccination hexavalente

Revue Medicale de Bruxelles

Volumn 25, Issue 4, 2004, Pages

  Swennen, B ^a,c   Levy J ^b  

^a Dept d'Epidemiol et de Med Prev   (Belgium)

^b SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Combination paediatric vaccines; Combined vaccine; DTPa HBV IPV Hib

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; ENGERIX B JUNIOR; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; POLIOMYELITIS VACCINE; RECOMBINANT HEPATITIS B VACCINE;

BACTERIAL INFECTION; CHILD; CHILD HEALTH CARE; CHILDHOOD DISEASE; DIPHTHERIA; DRUG EFFICACY; HAEMOPHILUS INFLUENZAE TYPE B; HEALTH CARE COST; HEALTH PROGRAM; HEPATITIS B; HUMAN; IMMUNIZATION; INFECTION CONTROL; PERTUSSIS; POLIOMYELITIS; PRACTICE GUIDELINE; REVIEW; TETANUS; VACCINATION; VIRUS INFECTION;

CHILD, PRESCHOOL; HUMANS; INFANT; VACCINES, COMBINED;

EID: 5044252900     PISSN: 00353639     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Ellis R: Development of combination vaccines. Vaccine 1999; 17: 1635-42
2. Gordon A: Vaccines and vaccination. N Engl J Med 2001; 345: 1042-53
3. Decker MD: Principles of pediatric combination vaccines and practical issues related to use in clinical practice. Pediatr Infect Dis J 2001; 20: S10-8
4. Plotkin SA: Immunologic correlates of protection induced by vaccination. Pediatr Infect Dis J 2001; 20: 63-75
5. Anonymous: Recommendations of the Advisory Committee on Immunization Practices (ACIP), the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians (AAFP): Combination Vaccines for Childhood Immunization. MMR 1999; 48 (RR05): 1-15
6. Gangarosa EJ, Galazka AM, Wolfe CR et al: Impact of antivaccine movements on pertussis control: the untold story. Lancet 1998; 351: 356-61
7. Capiau C, Poolman J, Hoet B et al: Development and clinical testing of multivalent vaccines based on a diphtheria-tetanus-acellular pertussis vaccine: difficulties encountered and lessons learned. Vaccine 2003; 21: 2273-87
8. Granoff DM, Holmes SJ, Osterholm MT et al: Induction of immunologic memory in infants primed with Haemophilus influenzae type b conjugate vaccines. J Infect Dis 1993; 168: 663
9. Ward JI, Broome CV, Harrison LH, Shinefield H, Black SB: Haemophilus influenzae type b vaccines: Lessons for the future. Pediatrics 1988; 81: 886-93
10. Hoppenbrouwers K, Kanra G, Roelants M et al: Priming effect, immunogenicity and safety of an Haemophilus influenzae type b-tetanus toxoid conjugate (PRP-T) and diphtheria-tetanus-acellular pertussis (DTaP) combination vaccine administered to infants in Belgium and Turkey. Vaccine 1999; 17: 875-86
11. Swennen B, Levy J: Oral poliomyelitis vaccine: time to change? Vaccine 2001; 19: 2262-7
12. Swennen B, Robert E: Enquête de couverture vaccinale des enfants de 18 à 24 mois en Communauté française (Bruxelles excepté). Rapport Communauté Française, PROVAC 2003
13. FitzSimons D, Fraņois G, Emiroglu N, Van Damme P: Combined hepatitis B vaccines. Vaccine 2003; 21: 1310-6
14. Rosenthal S, Chen R, Hadler S: The safety of acellular pertussis vaccines vs whole-cell pertussis vaccine. A postmarketing assessment. Arch Pediatr Adolesc Med 1996; 150: 457-60
15. Geier DA, Geier MR: An evaluation of serious neurological disorders following immunization: a comparison of whole-cell pertussis and acellular pertussis vaccines. Brain & Development 2004; 26: 296-300
16. Zepp F, Knuf M, Heininger U et al: Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants. Vaccine 2004; 22: 2226-33
17. Liese JG, Stojanov S, Berut F et al: Large scale safety study of a liquid hexavalent vaccine (D-T-acP-IPV-PRP-T-HBs) administrated at 2, 4, 6 and 12-14 months of age. Vaccine 2002; 20: 448-54
18. Aristegui J, Dal-Ré R, Diez-Delgado J et al: Comparison of the reactogenicity and immunogenicity of a combined diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio (DTPa-HBV-IPV) vaccine, mixed with the Haemophilus influenzae type b (Hib) conjugate vaccine and administered as a single injection, with the DTPa-IPV/Hib and hepatitis B vaccines administered in two simultaneous injections to infants at 2, 4 and 6 months of age. Vaccine 2003; 21: 3593-600
19. Edwards KM: Acellular pertussis vaccine - a solution to the pertussis problem? J Infect Dis 1993; 168: 15-20
20. Jefferson T, Rudin M, DiPietrantonj C: Systematic review of the effects of pertussis vaccines in children. Vaccine 2003; 21: 2003-14
21. Greco D, Salmaso S, Mastrantonio P et al: A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N Engl J Med 1996; 334: 341-8
22. Tozzi AE, Rava L, Ciofi degli Atti ML et al: Clinical presentation of Pertussis in unvaccinated and vaccinated children in the first six years of life. Pediatrics 2003; 112: 1069-75
23. Heininger U: Recent progress in clinical and basic pertussis research. Eur J Pediatr 2001; 160: 203-13
24. Swennen B, Sternon J: Les vaccins conjugués. Rev Med Brux 2002; 23: A237-46
25. Eskola J, Ward J, Dagan R, Goldblatt D, Zepp F, Siegrist CA: Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus- pertussis containing acellular pertussis. Lancet 1999; 354: 2063-8
26. Hargreaves RM, Slack MP, Howard AJ, Anderson E, Ramsay ME: Changing patterns of invasive Haemophilus influenzae disease in England and Wales after introduction of the Hib vaccination programme. BMJ 1996; 312: 160-1
27. McVernon J, Andrews N, Slack MPE, Ramsay ME: Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis. Lancet 2003; 361: 1521-3
28. Ramsay ME, McVernon J, Andrews NJ et al: Estimating Haemophilus influenzae type b vaccine effectiveness in England and Wales by use of the screening method. JID 2003; 188: 481-5
29. Haemophilus influenzae type b vaccine-booster campaign. Editorials. BMJ 2003; 326: 1158
30. Anonymous: From The European Agency for the Evaluation of Medicinal Products: Public statement Prevenar - Shortage of supply. EMEA/6659/04-Final
31. www.health.fgovbe/CSH_HGR
32. Greenberg DP, Pickering LK, Senders SD et al: Interchangeability of 2 Diphtheria-Tetanus-Acellular Pertussis vaccines in infancy. Pediatrics 2002; 109: 666-72